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Abstract Fanconi's anaemia (FA) is a rare autosomal recessive 
disease characterised by progressive pancytopoenia, a diverse 
assortment of congenital malformations, an increased sensitivity 
to reactive oxygen species and a predisposition to the develop-
ment of malignancies. In the present study, we assessed the 
propensity to undergo apoptosis of peripheral blood mononuclear 
cells (PBMC) from Italian FA patients. Cells were challenged by 
2-deoxy-D-ribose (dRib) or TNF-a plus cycloheximide as agents 
that induce apoptosis by interfering with cell redox status and 
mitochondrial membrane potential (MMP), and PBMC from FA 
patients resulted to be less prone to die than those from healthy 
subjects. The decreased susceptibility of FA cells to undergo 
apoptosis was also evident when another parameter highly 
correlated with the apoptotic process, i.e. MMP, was measured. 
Moreover, when A'-acetylcysteine was added to dRib-treated 
PBMC, a strong protection was evident either in PBMC from 
control subjects or from FA patients. These data indicate that an 
alteration of unknown nature of the mechanisms favouring 
apoptosis is present in freshly collected cells from FA patients, 
and that such alteration could contribute to the pathogenesis of 
the disease, and particularly to the increased susceptibility to 
cancer. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Fanconi's anaemia (FA) is a rare autosomal recessive dis-
ease ( ~ 1 out of 350 000) characterised by pancytopoenia, 
excess rate of chromosomal breakages, and an increased in-
cidence of non-lymphoid leukaemias and solid tumours [1]. 
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This paper is dedicated to the late Antonio Pagano, the beloved son of 
G.P., who recently lost his final battle against FA. 
More than five complementation groups have been recognised 
(currently classed as FA-A to FA-E) and two genes (FA C and 
FAA) have been located to chromosomes 9 and 16, respec-
tively, and cloned. FAD gene has been located to chromosome 
3 [2,3]. The fifth complementation group (FA-E) is currently 
regarded as a heterogeneous set of genetic subtypes [4]. FA 
cells are highly susceptible to DNA cross-linking agents such 
as mitomycin C (MMC) or diepoxybutane (DEB), resulting in 
increased chromosomal instability characterised by peculiar 
rearrangements. [5-7]. Moreover, alteration of cell cycle ki-
netics, such as G2 phase prolongation and arrest, as well as 
a disregulation of reactive oxygen species (ROS) production 
and/or antioxidant systems, seem to be a general feature of 
FA cells [8,9]. Overproduction of cytokines such as TNF-a 
has also been reported in FA either in vivo or in vitro [10,11]. 
Taking into account the intriguing relationship which exists 
between cell proliferation and cell death [12,13], as well as the 
role played by ROS and TNF-a in cancer progression and 
apoptosis [14-16], we thought it worthwhile to assess the pro-
pensity of FA cells to undergo apoptosis. The data presented 
here indicate that peripheral blood mononuclear cells (PBMC) 
from Italian FA patients, mostly belonging to complementa-
tion group A [17], are less prone to die when exposed to 2-
deoxy-D-ribose (dRib) or TNF-a plus cycloheximide (CHX), 
two conditions which induce apoptosis by interfering with cell 
redox status and mitochondrial membrane potential (MMP) 
[18,19]. 
2. Material and methods 
2.1. Patients 
The diagnosis of FA was confirmed by means of DEB test [20]. A 
total of seven patients (one female and six males) were recruited in 
this study. The patients were aged 5-18 years (mean± SD, 12.3 ± 1.6). 
Four of seven patients were clarified as homozygous for the FA-A 
gene, whereas two of seven patients, although being positive by 
DEB test, provided MMC-resistant lymphoblastoid cell lines. The 
haematological, genetic and clinical data of the patients are reported 
in Table 1. Ten normal, apparently healthy, age-matched volunteers 
(mean 12.7 ±1.3) were recruited as controls. In both cases the in-
formed consent of the parents was obtained. 
2.2. Cell culture and induction of apoptosis 
PBMC from FA patients and control subjects were separated by 
Ficoll-Hypaque sedimentation (Nycomed, Pharma AS, Oslo, Norway) 
and cultured at a density of 106 cells/ml in RPMI-1640 culture me-
dium, containing 2 mM L-glutamine, penicillin (100 U/ml) streptomy-
cin (100 ug/ml) and 10% heat-inactivated fetal calf serum (Gibco, 
Paisley, Scotland, UK). Cell suspensions were seeded into culture 
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Fig. 1. In situ DNA strand break-labeling (TUNEL) for detection of apoptotic cells after 48 h of incubation with dRib, revealed by fluores-
cence microscopy. Only positive nuclei appear coloured. a,b: Spontaneous apoptosis in control subjects and in FA patients, respectively. c,d: 
dRib-induced apoptosis, in control subjects and in FA patients, respectively. Magnification: 63X. 
plates in presence or absence of dRib (final concentration 10 mM) or 
TNF-oc plus CHX (50 U/ml and 16 uM, respectively) and then incu-
bated for 24 or 48 h at 37°C in humidified atmosphere of 5% CO2 in 
air. For studies on the protective effect of ./V-acetylcysteine (Sigma 
Chemical Co., St. Louis, MO), PBMC were incubated with dRib 
plus NAC (10 mM) for 24 and 48 h. Finally, cells were collected 
and analysed by different assays. 
2.3. Apoptosis assessment 
2.3.1. TdT-mediated dUTP nick end labeling. DNA fragmentation 
associated with apoptosis was detected by the TdT-mediated dUTP 
nick end labeling (TUNEL) technique using an in situ cell death 
detection kit (Boehringer Mannheim, Germany). dRib-treated 
PBMC were harvested and fixed in freshly prepared paraformalde-
hyde solution (4% in PBS, pH 7.4) on slides. After permeabilisation 
(with 0.1% Triton X-100, 0.1% sodium citrate), slides were incubated 
with TUNEL mixture containing terminal deoxynucleotidyl transfer-
ase (TdT) and fluorescein-dUTP. Finally, slides were analysed by 
fluorescence microscopy (Axioscope, Zeiss, Germany). Only the apop-
totic cells appeared coloured, while the non-apoptotic cells showed an 
absence of labelled nuclei. 
2.3.2. DNA content. Apoptosis quantification was evaluated by 
flow cytometry as reduced fluorescence of the propidium iodide (PI) 
in the apoptotic nuclei, according to Nicoletti et al. [21], as previously 
described [19]. Briefly, the 200Xg centrifuged cell pellet (106 cells) was 
gently resuspended in 500 |il of hypotonie fluorochrome solution (PI 
50 mg/ml in 0.1% sodium citrate plus 0.1% Triton X-100 in bidistilled 
water; Sigma Chemical Co.). Cells were analyzed by flow cytometry 
analysis after a minimum of 20 min of incubation in this solution. 
2.4. Mitochondrial membrane potential 
Mitochondrial membrane potential (MMP) was measured by the 
lipophilic cationic probe 5,5',6,6'-tetrachloro-l,l',3,3'-tetraethylbenzi-
midazolcarbocyanine iodide (JC-1, Molecular Probes, Eugene, OR), 
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with a method that has already been applied to apoptotic cells [22,23]. 
Cell suspension was adjusted to a density of 0.5 X106 cells/ml and 
incubated in complete medium for 10 min at room temperature in 
the dark with 10 ug/ml JC-1. At the end of the incubation period 
cells were washed twice in cold phosphate-buffered saline (PBS), re-
suspended in a total volume of 400 (xl and analyzed. 
2.5. Statistical analysis 
Statistical analysis was performed by an unpaired Student's t test. A 
P value lower than 0.05 was considered statistically significant. 
3. Results 
As expected, dRib was able to induce apoptosis in PBMC 
from control subjects and FA patients, as assessed by TU-
NEL. The propensity of PBMC from FA patients to undergo 
apoptosis was apparently lower than that of control subjects 
(Fig. ld,c). In contrast, spontaneous apoptosis was similar in 
the two groups (Fig. la,b). 
Using flow cytometry, it was possible to better quantify this 
phenomenon and to perform a time-course study. A marked 
and significant difference between FA patients and control 
subjects was observed after 48 h of culture (Fig. 2a). The 
decreased susceptibility of FA cells to undergo apoptosis 
was also evident when another parameter, related to the apop-
totic process, i.e. the decrease of MMP, was measured. Also in 
this case, the number of cells with depolarised mitochondria 
following dRib exposure was higher in control subjects than 
in FA cells, and this phenomenon was particularly evident 
after 48 h of culture (Fig. 2b). In a previous paper, we showed 
that the dRib-induced apoptosis and decrease of MMP were 
fully prevented by the addition of NAC, an agent capable of 
reversing the dRib-induced exhaustion of GSH intracellular 
pool [19], to the culture. When NAC was added to dRib-
treated PBMC a strong protection was evident not only in 
cells from control subjects but also in cells from FA patients 
(Fig. 3a,b). 
To test whether the lower propensity to undergo apoptosis 
was a general characteristic of FA cells, and taking into ac-
count the derangement of TNF-a level characteristic of the 
syndrome, we exposed cells from FA patients to TNF-a plus 
CHX, a well-known experimental model of apoptosis [18]. 
Owing to the shortage of cells it was possible to perform 
this study only in cells from several FA children. The percent-
age of either apoptotic cells or cells with depolarised mito-
chondria was lower in FA patients in comparison to control 
subjects, and a significant difference was observed for apop-
tosis at 48 h (Fig. 4a,b). 
4. Discussion 
In spite of the recent progress in localising and cloning 
some of the FA genes, a number of biological problems re-
main open, mainly concerning the role of such genes in bone 
marrow impairment, chromosomal instability and cancer 
proneness. 
An alteration of the propensity to undergo apoptosis could 
contribute to the FA phenotype and could be related to the 
above-mentioned major features of the syndrome. Previous 
reports on apoptosis in FA provided somewhat contradictory 
results. Rey et al. showed that MMC induced apoptosis in 
lymphoblastoid cells, but the level of DNA fragmentation 
48 and 96 h after MMC treatment was approximately the 
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same in cells from control subjects and FA patients [24]. The 
authors argued that the FA defect did not lead to abnormal 
apoptotic cell death. It is interesting to note that this conclu-
sion was reached on the basis of results obtained using a 
limited number of lymphoblastoid cell lines (one belonging 
to complementation group A, another to complementation 
group D, and one unclassified). Treating cells with y-rays, 
one of the several DNA-damaging agents capable of inducing 
apoptosis in cell culture [25], Rosselli et al. showed that 5 and 
10 Gy induced significantly less apoptosis in FA lymphoblas-
toid cell lines belonging to groups C and D than in control 
cells. This finding was related to a strong reduction of p53 
inducibility either by y-irradiation or MMC treatment [26]. In 
the same cell lines the spontaneous frequency of apoptotic 
cells was slightly more elevated in FA than in normal cell 
lines. Recently, using eight lymphoblastoid cell lines (belong-
ing to groups A, B, C and D) and MMC, y- and UV irradi-
ation as apoptotic inducers, Kruyt et al. found that FA lym-
phoblastoid cell lines were more responsive only when MMC 
was used. This result was apparently specific, being the same 
cell lines normally sensitive to y- and UV-induced apoptosis. 
Moreover, all the MMC-treated cell lines except one exhibited 
a clear increase in p53 expression [27]. These discrepancies can 
be partially explained by the fact that in all the above-men-
tioned investigations a limited number of EB-virus trans-
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Fig. 2. Percentage of apoptotic cells (a) and cells with depolarised 
mitochondria (b), assessed by cytofluorimetric analysis. PBMC cul-
tures were exposed to dRib for 24 or 48 h. A decrease in the per-
centage of apoptotic cells and cells with depolarised mitochondria 
was observed in FA cells treated with dRib at 48 h. Bars represents 
the mean ± SE of data concerning seven FA patients and 10 control 
subjects. **P<0.01, FA vs. control subjects. 
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Fig. 3. Protective effect of 7V-acetyl-L-cysteine (NAC) in dRib-in-
duced apoptosis (a) and mitochondria depolarisation (b) in PBMC 
from FA patients and control subjects, assessed by cytofluorimetric 
analysis. The protective effect of NAC on apoptosis was statistically 
significant only in FA cells at 24 h. A significant decrease concern-
ing the percentage of apoptosis and of cells with depolarised mito-
chondria was observed at 48 h in FA patients and control subjects. 
Bars represents the mean ± SE of data concerning six FA patients 
and four controls subjects. *P<0.05: FA or control subjects+dRib 
vs. FA or control subjects+dRib+NAC. 
formed FA lymphoblastoid cell lines have been used, and 
no ex vivo experiments were performed on cells taken directly 
from patients. These considerations are particularly appropri-
ate for studies aimed to a quantitative assessment of apopto-
sis, an intriguing event related to cell proliferation and trans-
formation. 
In the present study, apoptosis has been studied in freshly 
drawn PBMC taken from seven FA children, four of which 
are known to belong to complementation group A, as well as 
from 10 age-matched controls. dRib and TNF-oc were used as 
they are able to trigger apoptosis in human quiescent PBMC 
by inducing oxidative stress [19,28], thus mimicking a situa-
tion likely to occur in vivo in FA patients [9]. Moreover, a 
target of dRib and TNF-oc is the mitochondrion, an organelle 
critical for the occurrence of apoptosis [22,29,30]. In these 
experimental conditions, we found that spontaneous apoptosis 
was similar in FA and control cells, while dRib- and TNF-oc-
induced apoptosis was slightly but significantly reduced in FA 
cells. This conclusion is reinforced by the results obtained by 
studying the MMP, a parameter directly correlated to apop-
tosis in a variety of experimental systems including dRib and 
TNF-cc induced apoptosis [29,31]. 
On the whole, our data indicate that freshly collected 
PBMC from FA patients are relatively resistant to the induc-
tion of apoptosis by agents that interfere with the redox status 
of the cell. How can this finding be reconciled with the data 
suggesting that FA cells are more sensitive to oxidants and are 
D. Monti et al.lFEBS Letters 409 (1997) 365-369 369 
D FA patients Control subjects 
48 h 
4a 
24 h 
TNF+CHX-INDUCED 
SPONTANEOUS 
TNF + CHX-INDUCED 
SPONTANEOUS 
1 1 1 1 1 
10 20 30 40 50 
% APOPTOTIC NUCLEI 
4b 
48 h -
24 h ■ 
[—H TNF + CHX-INDUCED 
mmmjjjimsjS^m i SPONTANEOUS 
■,„„,„„,„„,„t2 TNF + CHX-INDUCED 
^wwwJj^î SPONTANEOUS 
10 20 30 40 50 60 70 
% CELLS WITH DEPOLARISED 
MITHOCONDRIA 
Fig. 4. Percentage of apoptotic cells (a) and cells with depolarised 
mitochondria (b), assessed by cytofluorimetric analysis. PBMC cul-
tures were exposed to TNF-a+CHX for 24 or 48 h. A decrease in 
the percentage of apoptotic cells and of cells with depolarised mito-
chondria was observed in FA cells treated with TNF-a+CHX at 48 
h. Bars represents the m e a n t SE of data concerning four FA pa-
tients and three control subjects. **P<0.01: FA vs. control sub-
jects. 
defective in antioxidant defence? Further studies are needed 
on this topic. A possible explanation is that the continuous in 
vivo exposure to oxidative stress can paradoxically make the 
cells more tolerant and resistant by inducing some antioxidant 
enzymes [32,33]. In particular, it has been shown that T N F - a 
is capable of inducing mitochondrial M n S O D , and thus pro-
tecting cells from cytotoxicity [34]. In conclusion, we suggest 
that an alteration of the mechanisms which favour apoptosis 
may contribute to the pathogenesis of FA, and particularly 
may be related to cancer proneness. 
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